Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -140,585 | -66,257 | -230,699 | -150,687 | -92,326 |
| Depreciation Amortization | 2,568 | 1,190 | 1,847 | 915 | 308 |
| Accounts payable and accrued liabilities | 2,649 | 2,672 | -1,958 | 116 | -207 |
| Other Working Capital | -14,980 | -17,750 | 15,003 | 2,912 | 2,608 |
| Other Operating Activity | 25,559 | 9,945 | 36,035 | 24,391 | 15,361 |
| Operating Cash Flow | $-124,789 | $-70,200 | $-179,772 | $-122,353 | $-74,256 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 119,287 | -7,427 | -160,364 | -210,601 | -226,537 |
| PPE Investments | -1,438 | 75,023 | -35,925 | -31,756 | -27,257 |
| Investing Cash Flow | $117,849 | $67,596 | $-196,289 | $-242,357 | $-253,794 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -235 | -98 | -528 | -396 | -272 |
| Common Stock Issued | 12,306 | 2,747 | 365,567 | 359,404 | 355,733 |
| Other Financing Activity | -6,670 | -4,575 | -7,503 | -7,493 | -3,431 |
| Financing Cash Flow | $5,401 | $-1,926 | $357,536 | $351,515 | $352,030 |
| Beginning Cash Position | 62,092 | 62,092 | 80,617 | 80,617 | 80,617 |
| End Cash Position | 60,553 | 57,562 | 62,092 | 67,422 | 104,597 |
| Net Cash Flow | $-1,539 | $-4,530 | $-18,525 | $-13,195 | $23,980 |
| Free Cash Flow | |||||
| Operating Cash Flow | -124,789 | -70,200 | -179,772 | -122,353 | -74,256 |
| Capital Expenditure | -1,534 | -796 | -35,925 | -31,756 | -27,257 |
| Free Cash Flow | -126,323 | -70,996 | -215,697 | -154,109 | -101,513 |